These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7106018)

  • 1. [Effect of live mumps vaccine alone and in combination with measles vaccine in infants].
    Vesikari T; Ala-Laurila EL; Heikkinen A; Kuusinen H; Terho A
    Duodecim; 1982; 98(11):839-47. PubMed ID: 7106018
    [No Abstract]   [Full Text] [Related]  

  • 2. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles, mumps, rubella vaccine and allergy to egg.
    Lang S
    Am Fam Physician; 1998 Sep; 58(4):863-4. PubMed ID: 9767722
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemolytic and uremic syndrome after measles, mumps and rubella vaccination. Fortuitous association?].
    Tsimaratos M; Le Menestrel S; Daniel L; Roquelaure B; Almhana T; de Montléon JV; Paut O; Picon G; Casanova P; Sarles J
    Arch Pediatr; 1997 Dec; 4(12):1261-2. PubMed ID: 9538434
    [No Abstract]   [Full Text] [Related]  

  • 6. National Advisory Committee on Immunization (NACI). Interim advisory on measles revaccination of persons with acquired immunodeficiency syndrome (AIDS).
    Can Commun Dis Rep; 1996 Jul; 22(14):116-7. PubMed ID: 8754936
    [No Abstract]   [Full Text] [Related]  

  • 7. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months.
    Gans H; Yasukawa L; Rinki M; DeHovitz R; Forghani B; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2001 Oct; 184(7):817-26. PubMed ID: 11528592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infant with febrile convulsions/incidental convulsions in the history: how does one proceed with diphtheria-pertussis-tetanus (DPT) and mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Burtzlaff C
    Kinderarztl Prax; 1993 Nov; 61(9):339-40. PubMed ID: 8114462
    [No Abstract]   [Full Text] [Related]  

  • 10. MMR vaccine is not linked to Crohn's disease or autism.
    Commun Dis Rep CDR Wkly; 1998 Mar; 8(13):113. PubMed ID: 9592960
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exanthema with high fever and cerebral seizure susceptibility after mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Mentel R
    Kinderarztl Prax; 1993 Aug; 61(6):227-8. PubMed ID: 8105135
    [No Abstract]   [Full Text] [Related]  

  • 13. [Leukemoid reaction or leukosis after MMR preventive vaccination].
    Wiersbitzky S; Peters A; Reddemann H
    Kinderarztl Prax; 1993 May; 61(3):118-9. PubMed ID: 8326701
    [No Abstract]   [Full Text] [Related]  

  • 14. [MMR-vaccinations and prevention of fatal cases].
    Jacobsen K
    Ugeskr Laeger; 1993 Sep; 155(37):2908. PubMed ID: 8259621
    [No Abstract]   [Full Text] [Related]  

  • 15. [Increased risk of invasive bacterial infections after preventive mumps-measles-rubella vaccination?].
    Wiersbitzky S; Bruns R; Mentel R
    Kinderarztl Prax; 1993 Jun; 61(4-5):170-1. PubMed ID: 8361148
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella].
    Autret E; Jonville-Béra AP; Galy-Eyraud C; Hessel L
    Therapie; 1996; 51(6):677-80. PubMed ID: 9164004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response.
    Halperin SA; McGrath P; Smith B; Houston T
    J Pediatr; 2000 Jun; 136(6):789-94. PubMed ID: 10839878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical safety issues of measles, mumps and rubella vaccines.
    Afzal MA; Minor PD; Schild GC
    Bull World Health Organ; 2000; 78(2):199-204. PubMed ID: 10743285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence to support current policy on MMR vaccination sent to doctors in the United Kingdom.
    Commun Dis Rep CDR Wkly; 1998 Apr; 8(14):123, 126. PubMed ID: 9592964
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.